Search our database for a full listing of enrolling studies
Collection of Blood and Tissue from Patients with Upper Aerodigestive Malignancies for Research Purposes (The UAM Tissue Resource) IRB 07-267 | HOSPITAL Main Campus | DISEASE Esophageal, GI (Gastrointestinal), Head and Neck, Lung, Lung – Mesothelioma, Lung – Pleural Mesothelioma, Thyroid
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
IRB RTOG 1008 | CC CC00031 | HOSPITAL Main Campus | PHASE Phase 2 | DISEASE Head and Neck, Salivary Gland
IRB CASE 4311 | CC CC00192 | HOSPITAL Main Campus | DISEASE Head and Neck
IRB RTOG 1216 | CC 13-420 | HOSPITAL Fairview, Hillcrest, Independence, Main Campus, Mansfield, North Coast Cancer, Parma, Strongsville, Wooster | DISEASE Head and Neck
IRB NRG HN001 | CC 14-691 | HOSPITAL Beachwood, Fairview, Hillcrest, Independence, Main Campus, Mansfield, North Coast Cancer, Strongsville, Wooster | PHASE Phase 2, Phase 3 | DISEASE Head and Neck, Nasopharyngeal Carcinoma
Molecular Analysis for Therapy Choice (MATCH)
IRB EAY 131 | CC 15-890 | HOSPITAL Main Campus | DISEASE All Cancer Types, Lymphoma
Tissue and Body Fluid Analysis from Patients with Cancer and Other Risk- Associated Lesions
IRB CASE 11Z15 | CC 15-1580 | HOSPITAL Fairview, Hillcrest, Main Campus | DISEASE All Cancer Types
IRB CASE 15Z16 | CC 17-498 |HOSPITAL Main Campus | DISEASE All Cancer Types
IRB CASE 4Z18 | CC 18-357 | HOSPITAL Main Campus | DISEASE All Cancer Types
IRB WCI 1318 | CC 18-1547 | HOSPITAL Main Campus | STAGE Recurrent/Relapsed | PHASE Phase 2 | DISEASE Head and Neck, Squamous Cell Carcinoma of H&N
A randomized Phase II study of re-irradiation of SBRT plus anti-PD-1 antibody Pembrolizumab (Keytruda®) versus SBRT Kalone for locoregionally recurrent or second primary head and neck carcinomathe head and neck
IRB RFI 1318 | CC 19-560 | HOSPITAL Main Campus | STAGE Recurrent/Relapsed | PHASE Phase 2 | DISEASE Head and Neck,
IRB MRK 1619 | CC 19-776 | HOSPITAL Main Campus | PHASE Phase 3 | DISEASE Head and Neck, Squamous Cell Carcinoma of H&N
IRB ACCRU 1Y19 | CC 19-058 | HOSPITAL Florida Weston, Main Campus | STAGE Stage 4 | PHASE Phase 3 | DISEASE All Cancer Types
IRB NRG HN004 | CC 19-1319 | HOSPITAL Main Campus, Mansfield, North Coast Cancer, Wooster | STAGE Advanced/Metastatic PHASE Phase 2, Phase 3 | DISEASE Head and Neck, Squamous Cell Carcinoma of H&N
IRB CASE 6319 | CC 19-1203 | HOSPITAL Main Campus | PHASE Phase 3 | DISEASE Head and Neck
Search our Head and Neck Clinical Trials Database for a full listing of all open and accruing studies.
Research on children with UHL explores the quality-of-life benefits and outcomes of cochlear implants
A look at how custom-fitted oral appliances work and when they’re a good fit for patients
Hearing loss and its treatments are often misunderstood by both the public and healthcare professionals
Modified Barium Swallow Study and Flexible Endoscopic Evaluation of Swallowing can both be used to diagnose dysphagia, but it’s important to understand their advantages and disadvantages
By working in tandem, a pediatric otolaryngologist and speech-language pathologist can diagnose conditions and develop treatment plans in the same visit
Because EILO is a relatively new condition, educating care providers to help diagnose and treat earlier is critical
A Cleveland Clinic speech-language pathologist describes the techniques she uses with her patients and how new research reinforces that patients should be driving care decisions
The treatment is simple and effective for many patients, but more research is needed to determine the exit-strategy from repetitive injections